Form 13-F position report

BRIDGEBIO PHARMA INC

Reported by STEELHEAD PARTNERS LLC

BBIO 2.5 03/15/27 CUSIP 10806XAB8 Manager CIK 0001133521

Reported 55,000,000 shares, down 15,000,000 (21.4%) from the prior quarter.

Reported value -31.4%; share count -21.4% vs. the prior quarter.

Reduced
% of reported 13F value 5.29% This manager · Q3 2026
Shares 55,000,000 Quarter-end amount reported
Reported value $85,582,310 Fair value at quarter end
Consecutive quarters held 3 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-03-31 126632940
2026-06-30 124775000
2026-09-30 85582310

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for BRIDGEBIO PHARMA INC held by STEELHEAD PARTNERS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 55,000,000 -15,000,000 (-21.4%) 5.29% $85,582,310 2026-11-13
Q2 2026 Unchanged 70,000,000 0 (0.0%) 8.9% $124,775,000 2026-08-14
Q1 2026 New 70,000,000 +70,000,000 (0.0%) 9.1% $126,632,940 2026-05-13

Who else reported the position

45 managers reported BRIDGEBIO PHARMA INC for Q3 2026.

Managers reporting BRIDGEBIO PHARMA INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
AMUNDI Unchanged 2,300,000 0 0.07% $355,465,000 8 qtrs
WOLVERINE ASSET MANAGEMENT LLC Unchanged 0 0 1.21% $180,289,564 12 qtrs
CAPSTONE INVESTMENT ADVISORS LLC Added 104,888,000 +35,016,000 0.24% $162,628,844 5 qtrs
DeepCurrents Investment Group LLC Added 57,745,000 +7,500,000 2.58% $89,834,485 3 qtrs
STEELHEAD PARTNERS LLC This report Reduced 55,000,000 -15,000,000 5.29% $85,582,310 3 qtrs
ExodusPoint Capital Management LP New 45,500,000 +45,500,000 0.37% $70,850,489 1 qtr
BOUSSARD & GAVAUDAN GESTION SAS Added 35,000 +6,000 4.27% $55,199,638 2 qtrs
Bank of America Corporation Added 30,777,000 +17,767,000 < 0.01% $47,565,854 10 qtrs
Graham Capital Management L P Unchanged 22,241,000 0 0.51% $34,588,727 13 qtrs
TENOR CAPITAL MANAGEMENT Co L P New 16,500,000 +16,500,000 0.32% $25,683,494 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
NOTE 2.500% 3/1

Voting authority reported

Sole
55,000,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.